Diabetes affects 382 million people worldwide. ManageBGL is for people with both Type 1 (Insulin-dependent, IDDM) and Type 2 diabetes and their carers, and predicts dangerous low blood sugars up to 8 hours ahead. The person enters blood sugar and carbohydrates, and ManageBGL calculates the insulin dose, and then predicts the complex curve the blood sugar will follow.
ManageBGL is the brain-child of Simon Carter, founder and long-term Type 1 diabetic, father of a diabetic child and software entrepreneur.
“The ability to predict blood sugars ahead of time is new, and doctors have a hard time believing it can be done. After we explain it, doctors go from disbelief to saying – this is a really clever idea” says Simon. “Whether it is at school, or predicting dangerous low blood sugars overnight, ManageBGL reduces the risks and constant stresses of having diabetes.”
ManageBGL also seeks to reduce the massive costs of intensive insulin therapy. By providing the same dose calculations and tracking of insulin remaining as an insulin pump, it saves $5000 and $1000/year in pump consumables. The patient injects normally with syringes or insulin pens. It also offers blood sugar history comparable to a Continuous Glucose Monitor, saving $5000 and $1000/year.
ManageBGL is now crowd-funding on Indiegogo.com to develop a medical-grade app to run offline on iPhone and Android smart phones and tablets. Link: http://www.indiegogo.com/
ManageBGL is offered worldwide, with a 14-day free trial period, then USD 100/year.